IceCure Medical reported Q1 2025 revenue of $725.0K (-1.5% YoY), missed analyst consensus of $900.5K by $175.5K. Diluted EPS came in at $-0.06 (+25.0% YoY), beat the $-0.08 consensus by $0.02.
Filings will appear here once submitted to SEC EDGAR.
Common questions about IceCure Medical's Q1 2025 earnings report.
IceCure Medical (ICCM) reported Q1 2025 earnings on May 28, 2025 before market open.
IceCure Medical reported revenue of $725.0K and diluted EPS of $-0.06 for Q1 2025.
Revenue missed the consensus estimate of $900.5K by $175.5K. EPS beat the consensus estimate of $-0.08 by $0.02.
Compared to the same quarter a year prior, revenue declined 1.5% from $736.4K a year earlier and diluted EPS grew 25.0% from $-0.08.